Perils of self-managed medical abortion: an observational study in aspirational district Fatehpur, Uttar Pradesh, India
Keywords:
Keywords: self-managed abortion, medical abortion, mifepristone, misoprostol, MTP Pill, MTP Act, maternal morbidity, IndiaAbstract
Background
Despite legislation governing medical termination of pregnancy (MTP), many women self-administer MTP pills
without medical supervision. This study aims to investigate the maternal morbidity and mortality associated with
the use of self-managed abortion pills and the various factors contributing to their misuse.
Methodology
We conducted a prospective, hospital-based observational study at Amar Shaheed Jodha Singh Attaiya Thakur
Dariyaon Singh Medical College, Fatehpur, Uttar Pradesh. Eligible women were consecutively enrolled during
routine clinical care between 1 July 2024 and 30 June 2025. Two hundred thirty-nine pregnant women who reported
to the outpatient department (OPD) or the emergency room with a history of taking the MTP pill (mifepristone–
misoprostol combination) without a valid medical prescription, whether procured by themselves or by another
person over the counter, were included in the study.
Results
Of 239 participants, most (76.15%) were aged 20–30 years. Over half (55.23%) were from rural areas, and 53.97%
belonged to the middle class. The majority (64.02%) had two or more children, and 61.51% had vaginal deliveries.
At the time of taking the MTP pill, 64.01% were under 12 weeks pregnant. Nearly one-third (31.80%) sought hospital
care more than 30 days after taking the pill. Severe anemia occurred in 21 participants, while 3 required ICU care, 3
developed sepsis, and 1 underwent laparotomy for ectopic pregnancy or perforation. No maternal deaths were
reported. Only 40.59% assessed their eligibility for medical abortion, and awareness of possible complications was
low (12.97%).
Conclusion
Using MTP pills without medical supervision can lead to severe and potentially life-threatening complications. It is
imperative to restrict easy and unrestricted access to these medications, necessitating the implementation of
stringent regulations targeting both individuals seeking the pills and those providing them.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.